{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3708, 
        3715
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3865, 
        3871
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3891, 
        3901
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3692, 
        3701
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3716, 
        3725
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3872, 
        3881
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6935, 
        6958
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3547, 
        3574
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3358, 
        3362
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3591, 
        3595
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3654, 
        3658
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3363, 
        3376
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3579, 
        3589
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        656, 
        685
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6858, 
        6893
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3327, 
        3353
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4096, 
        4152
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4207, 
        4263
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3675, 
        3683
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3882, 
        3889
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4", 
      "__extent": [
        4142, 
        4152
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4", 
      "__extent": [
        4253, 
        4263
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3731, 
        3760
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3844, 
        3864
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5196, 
        5197
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3646, 
        3652
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3684, 
        3691
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4048, 
        4054
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4157, 
        4163
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Steven", 
      "__extent": [
        3355, 
        3357
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Steven", 
      "__extent": [
        3377, 
        3379
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3403, 
        3405
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3472, 
        3474
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Steven", 
      "__extent": [
        3576, 
        3578
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3643, 
        3645
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4045, 
        4047
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4154, 
        4156
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4265, 
        4282
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D0658987^CLIA|eMARCPlus|TN Cancer Registry|20170919125833||ORU^R01^ORU_R01|201709191258330001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-51-003190^PathSys^44D0658987^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170809000000|||||||20170809000000|&Sentinel Lymph Node, Breast, Exc. of Lesion, requiring micro. margins, Breast, Exc. of Lesion, requiring micro. margins, Breast, Exc. of Lesion, requiring micro. margins|1538157219^^^^^^MD^^CMS^D^^^NPI||||||20170811000000|||F||||||C50.912^Malignant neoplasm of unspecified site of left female breast^I10|1487897187&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received fresh for intraoperative consultation labeled with the patient's name and designated \"left sentinel node #1 and #2\" is 1 fragment of yellow-red fibroadipose tissue measuring 4 x 2.5 x 0.6 cm. The surgeon has inserted a stitch to designate lymph node #1. This node measures approximately 1.2 mm. Sectioning of the specimen reveals another potential lymph node measuring 1 mm. Node #1 is inked black and node #2 is inked blue. Half of each node is submitted for frozen analysis, 2/1. The remaining lymph node fragments are entirely submitted in cassette A, 4/1. 2. Received fresh is a 21 g lumpectomy specimen that is oriented by the surgeon with a long suture marking lateral, short suture marking superior, an uneven suture marking deep, and a single suture marking superficial. The specimen measures 5 cm from superficial to deep x 4.6 cm from medial to lateral x 2.5 cm from superior to inferior. The specimen is inked as follows: Superior-blue, inferior-green, medial- orange, lateral-yellow, anterior-red, posterior-black. The specimen is serially sectioned from anterior to posterior to reveal a poorly circumscribed sclerotic mass measuring approximately 1.5 cm and is focally approaching the superior margin at approximately 2 to 3 mm. (FLC/jh9) Post fixation: The remainder of the jut surface is composed of yellow lobulated adipose tissue with approximately 1-5% associated gray-white fibroglandular tissue. No other gross abnormalities are identified. Representative sections are submitted for permanent sections as follows: 2A-2D, the entire mass to include the lateral, superior, and inferior margins, 1/1 each; 2E, posterior margin, 2/1; 2F, medial margin, 1/1; 2G, anterior margin, 2/1. 3. Received in fixative labeled \"\" and \"additional medial margin, stitch on new medial site\" is a 2.7 x 2.0 x 1.2 cm piece of yellow lobulated adipose tissue. A suture is attached to 1 side and is designated as the new medial margin. This surface is marked with orange ink. Serially sectioning the tissue reveals no discrete lesions or other gross abnormalities. The specimen is entirely submitted from medial to lateral in cassettes 3A-3C, 1/1 each. 4. Received in fixative labeled \"\" and \"additional superior margin, stitch on the superior side\" is a 3.0 x 2.2 x 1.5 cm piece of yellow lobulated adipose tissue. One surface has an attached suture that is designated as the new superior side. This aspect is marked with blue ink. Serially sectioning the tissue reveals no discrete lesions or other gross abnormalities. The specimen is entirely submitted from superior to inferior in cassettes 4A-4C. 1/1 each. (MLL/HMJ/sc1)\n\n\nPath report.site of origin\n\n1. Left sentinel node 2. Left medial lumpectomy 3. Additional medial margin, stitch on new medial side for permanent 4. Additional superior margin, stitch on new superior side for permanent\n\n\nPath report.final diagnosis\n\n1. Lymph node, left sentinel, excision:     One benign lymph node. 2. Breast, left lumpectomy:     Invasive mammary carcinoma, pure tubular carcinoma.     Low combined histologic grade, low proliferative rate.     Tumor measures 11 mm in greatest dimension.     Focal associated low-grade ductal carcinoma in situ, cribriform type.     In situ and invasive carcinoma are closest to the lateral and superior margins       at 4 mm.     All other margins widely negative. 3. Breast, additional medial margin, excision:     Negative for atypical breast proliferation or malignancy. 4. Breast, additional superior margin, excision:     Negative for atypical breast proliferation or malignancy. CANCER CHECKLIST: INVASIVE CARCINOMA OF THE BREAST: Complete Excision (Less Than Total Mastectomy, Including Specimens Designated Biopsy, Lumpectomy, Quadrantectomy, and Partial Mastectomy With or Without Axillary Contents) and Mastectomy (Total, Modified Radical, Radical With or Without Axillary Contents)Radical, Radical With or Without Axillary Contents) 2.006.001.1000043 SPECIMEN  Procedure: Excision with image-guided localization  Lymph Node Sampling: Sentinel lymph node(s)  Specimen Laterality: Left TUMOR  Histologic Type: Tubular carcinoma  Glandular (Acinar) / Tubular Differentiation: Score 1 (> 75% of tumor area forming glandular / tubular structures)  Nuclear Pleomorphism: Score 1 (Nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size)  Mitotic Rate: Score 1 (<=3 mitoses per mm2)  Overall Grade: Grade 1 (scores of 3, 4 or 5)  Ductal Carcinoma In Situ (DCIS): DCIS is present, Negative for extensive intraductal component (EIC)  Architectural Patterns: Cribriform  Nuclear Grade (see Table 2 in CAP Protocol): Grade I (low)  Necrosis: Not identified  Lobular Carcinoma In Situ (LCIS): Not identified  Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion > 1 mm  Greatest Dimension (mm): 11mm  Tumor Focality: Single focus of invasive carcinoma Macroscopic and Microscopic Extent of Tumor  Skin: Skin is not present  Skeletal Muscle: No skeletal muscle is present Accessory Tumor Findings  Lymph-Vascular Invasion: Not identified  Dermal Lymph-Vascular Invasion: No skin present  Microcalcifications: Not identified  Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy: No known presurgical therapy MARGINS  Invasive Carcinoma: Margins uninvolved by invasive carcinoma  Superior: 4mm, 4mm LYMPH NODES  Sentinel Node Status: Sentinel lymph node biopsy performed  Number of Sentinel Nodes Examined: Specify number  Specify number: 1  Method of Evaluation of Sentinel Lymph Node(s): H and E, multiple levels  Number of Lymph Node(s) Examined (sentinel and nonsentinel): Specify number  Specify number: 1  Lymph Node Involvement: None identified STAGE (pTNM)  TNM Descriptors: Not applicable  Primary Tumor (Invasive Carcinoma) (pT): pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension  Modifier: (sn): Only sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used.  Category (pN): pN0: No regional lymph node metastasis identified histologically\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Left breast cancer, invasive\n\n\n"
}